40 commercial payer policies list J0791. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
40 policies from 23 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Codes labeled “Inferred from policy title” are not listed in the policy document; Backwork attached them because the policy title names the drug.
| Policy | Effective | Status of J0791 |
|---|---|---|
| Adakveo (crizanlizumab-tmca) | Jan 1, 2025 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Adakveo (crizanlizumab-tmca) | Feb 1, 2024 | Prior auth requiredInferred from policy title |
| Adakveo (crizanlizumab-tmca) | Jan 1, 2026 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Crizanlizumab-tmca (Adakveo) | Feb 1, 2023 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Crizanlizumab-tmca (Adakveo) | Mar 1, 2020 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Crizanlizumab-tmca (Adakveo) | Mar 1, 2022 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Crizanlizumab-tmca (Adakveo) | Mar 15, 2021 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Policy | Effective | Status of J0791 |
|---|---|---|
| Adakveo (Crizanlizumab-Tmca) | May 1, 2026 | Covered |
| Provider Administered Drugs – Site of Care | Oct 1, 2026 | Covered |
| Adakveo (Crizanlizumab-Tmca) – Commercial and Individual Exchange Medical Benefit Drug Policy | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Adakveo (Crizanlizumab-Tmca) – Community Plan Medical Benefit Drug Policy | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J0791 |
|---|---|---|
| Crizanlizumab-tmca (Adakveo) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Crizanlizumab-tmca (Adakveo) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J0791 |
|---|---|---|
| Crizanlizumab-tmca | Apr 1, 2026 | Covered |
| Specialty Medication Administration Site of Care | Jan 1, 2026 | Covered |
| Policy | Effective | Status of J0791 |
|---|---|---|
| Crizanlizumab-tmca | Apr 1, 2026 | Covered |
| Specialty Medication Administration Site of Care | Jan 1, 2026 | Covered |
| Policy | Effective | Status of J0791 |
|---|---|---|
| Crizanlizumab-tmca | Apr 1, 2026 | Covered |
| Specialty Medication Administration Site of Care | Jan 1, 2026 | Covered |
| Policy | Effective | Status of J0791 |
|---|---|---|
| Crizanlizumab-tmca | Apr 1, 2026 | Covered |
| Specialty Medication Administration Site of Care | Jan 1, 2026 | Covered |
| Policy | Effective | Status of J0791 |
|---|---|---|
| Adakveo (crizanlizumab-tmca) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| State and School Employees' Health Insurance Plan - Adakveo (crizanlizumab-tmca) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J0791 |
|---|---|---|
| Crizanlizumab-tmca (Adakveo) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Crizanlizumab-tmca (Adakveo) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J0791 |
|---|---|---|
| Adakveo (Crizanlizumab-Tmca) | May 1, 2026 | Covered |
| Provider Administered Drugs – Site of Care | Oct 1, 2026 | Covered |
| Policy | Effective | Status of J0791 |
|---|---|---|
| Crizanlizumab (e.g., Adakveo) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J0791 |
|---|---|---|
| ADAKVEO (CRIZANLIZUMAB-TMCA) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J0791 |
|---|---|---|
| Crizanlizumab Tmca Adakveo | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J0791 |
|---|---|---|
| Crizanlizumab-tmca(Adakveo) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J0791 |
|---|---|---|
| Crizanlizumab-tmca (Adakveo) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J0791 |
|---|---|---|
| Crizanlizumab-tmca (Adakveo); CP.PHAR.449 | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J0791 |
|---|---|---|
| Crizanlizumab-tmca (Adakveo) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J0791 |
|---|---|---|
| Crizanlizumab-tmca (Adakveo) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J0791 |
|---|---|---|
| 00704 Novel Treatments for Sickle Cell Disease (Adakveo) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J0791 |
|---|---|---|
| Adakveo (crizanlizumab-tmca) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J0791 |
|---|---|---|
| Adakveo (crizanlizumab) (PG193, Ver. 3) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J0791 |
|---|---|---|
| Adakveo (crizanlizumab-tmca) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J0791 |
|---|---|---|
| Adakveo (Crizanlizumab-Tmca) | May 1, 2026 | Covered |